Reveals biodistribution and clearance patterns of carbon nanotubes in zebrafish, indicating potential biomedical applications.
in blood and gut tissues from the T1 group, and faster clearance in blood compared to gut. By day 28, MWCNTs showed higher accumulation in the liver, followed by the gut and brain. This study delineates the pharmacokinetics and biodistribution, and confirms the optimal dose of MWCNTs, and promotes its application in the field of biomedical research.
No takes yet. Share an insight, caveat, or question.
Kumari et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: